SCFAs protect against DSS-induced colitis (26–28) and prevents the formation of inflammatory-associated CRC by ameliorating colon inflammatory processes and limiting the activation of NF-κB and the expression of COX-2 (27). This evidence concerns the gene NFKB1 and colorectal carcinoma.